Synopsys INC Form 4 insider transactions

NASDAQ
Synopsys CFO Shelagh Glaser reported the vesting of 793 restricted stock units and the subsequent sale of 282 shares to cover tax obligations.
NASDAQ
Synopsys President and CEO Sassine Ghazi reported the vesting of restricted stock units and a subsequent sale of shares to cover tax obligations.
NASDAQ
Synopsys Executive Chair Aart de Geus reported the acquisition of 1,763 shares of common stock through RSU vesting and the disposition of 630 shares for tax obligations.
NASDAQ
Synopsys General Counsel Janet Lee reported the vesting of 292 Restricted Stock Units and the subsequent disposition of 127 shares for tax withholding purposes.
NASDAQ
Synopsys Inc. Director Peter A. Shimer was granted 925 shares of common stock through an automatic equity award plan.
NASDAQ
Synopsys' General Counsel and Corporate Secretary, Janet Lee, reported the vesting of restricted stock units and a subsequent sale of shares to cover tax obligations.
NASDAQ
Synopsys Executive Chair Aart de Geus has a pre-planned acquisition of 28 shares of common stock through an employee stock purchase plan set for February 27, 2026.
NASDAQ
Synopsys CFO Shelagh Glaser reported a planned acquisition of 28 shares of common stock at $351.90 per share through an employee stock purchase plan.
NASDAQ
Synopsys President and CEO Sassine Ghazi is scheduled to acquire 28 shares of common stock at $351.90 per share through an employee stock purchase plan.
NASDAQ
Synopsys Chief Accounting Officer Sudhindra Kankanwadi acquired 28 shares of common stock through an employee stock purchase plan.
NASDAQ
Synopsys General Counsel Janet Lee sold 250 shares of common stock at $530 per share, executed under a pre-arranged 10b5-1 plan.
NASDAQ
Synopsys' General Counsel and Corporate Secretary, Janet Lee, sold 250 shares of common stock at $510 per share on January 7, 2026, under a pre-arranged trading plan.
NASDAQ
Synopsys General Counsel Janet Lee reported the vesting of restricted stock units and subsequent tax-related share dispositions on December 31, 2025.
NASDAQ
Synopsys CFO Shelagh Glaser reported the exercise of stock options and subsequent sale of common stock totaling 3,657 shares under a Rule 10b5-1 plan.
NASDAQ
Synopsys Chief Revenue Officer Michael Ellow reported the grant of 6,475 restricted stock units and an update to his indirect common stock holdings.
NASDAQ
Synopsys Inc.'s CFO, Shelagh Glaser, received a grant of 7,554 restricted stock units under the company's 2006 Employee Equity Incentive Plan.
NASDAQ
Synopsys Inc.'s Chief Accounting Officer, Sudhindra Kankanwadi, was granted 4,317 restricted stock units under the company's equity incentive plan.
NASDAQ
Synopsys Inc.'s Executive Chair, Aart de Geus, was granted 2,693 restricted stock units under the company's 2006 equity incentive plan.
NASDAQ
Synopsys, Inc. President and CEO Sassine Ghazi was granted 19,856 restricted stock units under the company's 2006 Employee Equity Incentive Plan.
NASDAQ
Synopsys Inc.'s General Counsel and Corporate Secretary, Janet Lee, was granted 3,238 restricted stock units under the company's 2006 Employee Equity Incentive Plan.
NASDAQ
Synopsys, Inc.'s Chief Revenue Officer, Michael Ellow, was granted 24,286 restricted stock units under the company's 2006 Employee Equity Incentive Plan.
NASDAQ
Synopsys President and CEO Sassine Ghazi reported the vesting of restricted stock units and subsequent share dispositions for tax obligations.
NASDAQ
Synopsys CFO Shelagh Glaser reported the vesting of restricted stock units and subsequent disposition of shares to cover tax obligations on December 8, 2025.
NASDAQ
Synopsys Chief Accounting Officer Sudhindra Kankanwadi reported the vesting of restricted stock units and subsequent tax-related share disposals on December 8, 2025.
NASDAQ
Synopsys Executive Chair Aart de Geus reported the vesting and exercise of restricted stock units and subsequent tax-related share dispositions on December 8, 2025.
NASDAQ
Synopsys GC & Corporate Secretary Janet Lee reported the vesting of restricted stock units and subsequent sale of shares for tax obligations.
NASDAQ
Synopsys General Counsel Janet Lee reported the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.
NASDAQ
Synopsys Chief Accounting Officer Sudhindra Kankanwadi exercised stock options and sold shares, realizing over $6.4 million in net proceeds from pre-planned transactions.
NASDAQ
Synopsys Director Robert G. Painter acquired 350 shares of common stock at $425.4397 per share under a pre-arranged trading plan.
NASDAQ
Synopsys Inc. Director Ravi K Vijayaraghavan received automatic equity awards totaling 1,140 shares of common stock under the company's non-employee director plan.